Comparative Outcomes of Basal Insulin and Oral Anti-Diabetic Agent as an Add-On to Dual Therapy in Patients With Type 2 Diabetes Mellitus

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.07.274